Loading…
Based on limited metadata with no full letter text available, Reedhill Ventures LLC received an FDA Warning Letter on March 29, 2018, though the specific subject matter and detailed violations cannot be determined from the available information. The company appears to be involved with a product category classified as "Other," which does not clearly indicate whether the product falls under drugs, devices, cosmetics, or another FDA-regulated category. Without access to the complete letter or the issuing office designation, the specific regulatory framework and nature of the compliance issues cannot be accurately characterized.